InnovAge Holding (INNV) Gains from Sales and Divestitures (2022)

InnovAge Holding (INNV) posted Gains from Sales and Divestitures of $844081.0 for Q4 2022, up 1538.39% quarter-over-quarter from $51519.0 in Q3 2022.

InnovAge Holding (INNV) Gains from Sales and Divestitures (2022) Analysis & Trends

InnovAge Holding (INNV) has reported Gains from Sales and Divestitures for 1 consecutive years, with $844081.0 the latest figure, recorded in Q4 2022.

  • Gains from Sales and Divestitures for Q4 2022 came in at $844081.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $844081.0 (changed N/A YoY), and the FY2022 annual result was $1.6 million, changed N/A from the prior year.
  • Gains from Sales and Divestitures was $844081.0 for Q4 2022 at InnovAge Holding, up from $51519.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $1.6 million in Q2 2022 and troughed at $51519.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 InnovAge Holding 1.59 Bn 1.50 Bn 243.20 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 844,081.00
Dec 31, 2022 844,081.00
Sep 30, 2022 51,519.00
Sep 30, 2022 51,519.00
Jun 30, 2022 1.62 Mn
Jun 30, 2022 1.62 Mn